FIELD: pharmacology; veterinary medicine.
SUBSTANCE: invention relates to the field of pharmacology and veterinary medicine, and it is aimed to correcting action of animal growth and development. The use of a clathrate complex containing 20-hydroxyecdysone and arabinogalactan is described for an increase in non-specific resistance, anti-oxidant status of an organism, growth and development of animals.
EFFECT: effective increase in non-specific resistance, antioxidant status of an organism, growth and development of animals at the same time.
1 cl, 9 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR NORMALIZATION OF METABOLISM, INCREASE OF NON-SPECIFIC RESISTANCE, GROWTH AND DEVELOPMENT OF ANIMALS | 2019 |
|
RU2768456C2 |
| CLATHRATE COMPLEX OF ARABINOGALACTAN OR ARABIC GUM WITH 20-HYDROXYECDYSONES, METHOD FOR PRODUCING IT (VERSIONS), PHARMACEUTICAL COMPOSITION AND MEDICINAL PRODUCT | 2013 |
|
RU2572334C2 |
| USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR CORRECTION OF METABOLIC DISORDERS | 2019 |
|
RU2768171C2 |
| METHOD FOR OXIDATIVE STRESS CORRECTION UNDER CONDITIONS OF ULTRAVIOLET IRRADIATION | 2016 |
|
RU2619875C1 |
| METHOD FOR COMBINED USE OF INTRANASALLY ADMINISTERED INSULIN AND ORALLY ADMINISTERED METFORMIN FOR RECOVERY OF METABOLIC AND HORMONAL PARAMETERS IN TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME | 2023 |
|
RU2824275C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TYPE 2 DIABETES MELLITUS AND MEDICINE ON ITS BASIS | 2009 |
|
RU2435593C2 |
| ANTIDIABETIC AGENT WITH HYPOLIPIDEMIC ACTIVITY FOR TREATMENT AND PREVENTION OF INSULAR DIABETES II TYPE | 2007 |
|
RU2337698C1 |
| CORRECTIVE COMPOSITION FOR PATHOLOGIC CARBOHYDRATE, LIPID DISBOLISM AND ANTIOXIDANT ORGANISM STATE INVOLVEMENT | 2008 |
|
RU2360683C1 |
| METHOD OF IMPROVEMENT OF LIVER FUNCTION | 2013 |
|
RU2653478C2 |
| METHOD FOR INCREASING GENERAL NONSPECIFIC RESISTANCE OF MAMMAL BODY | 2009 |
|
RU2395960C1 |
